LoginRegister
    Clarus Therapeutics gets USFDA nod to Jatenzo for treatment of hypogonadismClarus Therapeutics gets USFDA nod to Jatenzo for treatment of hypogonadism
    SL Raheja Hospital launches Institute of Digestive and Liver CareSL Raheja Hospital launches Institute of Digestive and Liver Care
    Newly approved MS drug Mayzent priced at USD 88000: NovartisNewly approved MS drug Mayzent priced at USD 88000: Novartis
    Strides Pharma gets USFDA approval for Oral Dosage facility in SingaporeStrides Pharma gets USFDA approval for Oral Dosage facility in Singapore
    Purdue Pharma agrees to pay $270 million to settle opioid casePurdue Pharma agrees to pay $270 million to settle opioid case
    Amrapali Hospital Auction: Only One Single bid of Rs 13.74 crore made, rejectedAmrapali Hospital Auction: Only One Single bid of Rs 13.74 crore made, rejected
    FDC Rationality: Now 6 months accelerated stability study data to be submitted, directs DCGIFDC Rationality: Now 6 months accelerated stability study data to be submitted, directs DCGI
    Sandoz launches generic Treprostinil InjectionSandoz launches generic Treprostinil Injection
    AstraZeneca gets EU nod to diabetes drug ForxigaAstraZeneca gets EU nod to diabetes drug Forxiga
    Alembic Pharma gets USFDA nod to Tadalafil tablets for treating erectile dysfunctionAlembic Pharma gets USFDA nod to Tadalafil tablets for treating erectile dysfunction
    USFDA approves Novartis oral drug Mayzent to treat multiple sclerosisUSFDA approves Novartis' oral drug Mayzent to treat multiple sclerosis
    JnJ, Bayer settles Xarelto lawsuits for 775 million DollarJnJ, Bayer settles Xarelto lawsuits for 775 million Dollar
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X